Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla
Clinical trials sponsored by Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla, explained in plain language.
-
Can a Salt-Marsh plant supplement beat high cholesterol?
Disease control Not yet recruitingThis study tests a dietary supplement made from salicornia (a salt-marsh plant) and B vitamins in 250 adults aged 40-65 with newly diagnosed high cholesterol who do not yet need medication. Participants will either take the supplement or follow standard care, and researchers will…
Phase: NA • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated May 17, 2026 11:39 UTC
-
Could a common blood thinner boost antibiotics against deadly staph infections?
Disease control Not yet recruitingThis study tests whether adding clopidogrel, a drug usually used to prevent blood clots, to standard antibiotics can improve outcomes for people with a serious Staphylococcus aureus bloodstream infection. About 230 hospitalized adults will be randomly assigned to receive either s…
Phase: PHASE2 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated May 17, 2026 11:33 UTC
-
AI-Powered therapy for teens: a new hope for emotional struggles?
Symptom relief Not yet recruitingThis study tests a brief psychological program called AGENCIA, which uses digital tools and artificial intelligence to help teens aged 12-18 with emotional and behavioral issues like irritability, impulsivity, and conflicts. Participants are randomly assigned to an online self-gu…
Phase: NA • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
New hope for seniors with stubborn depression: esketamine spray vs aripiprazole pill
Symptom relief Not yet recruitingThis study tests whether esketamine nasal spray works better than aripiprazole pills for older adults (60-74 years) whose depression hasn't improved with standard antidepressants. Both treatments are added to the patient's current antidepressant. The main goal is to see if sympto…
Phase: PHASE3 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Symptom relief
Last updated May 11, 2026 20:49 UTC
-
New study aims to predict dangerous infections in blood cancer patients
Knowledge-focused Not yet recruitingThis study looks at blood cancer patients who carry drug-resistant bacteria in their gut. Researchers will use weekly rectal swabs to track these bacteria and develop a score to predict who will get a serious infection. The goal is to better protect patients during chemotherapy o…
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Knowledge-focused
Last updated May 17, 2026 11:32 UTC